Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 1,818 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Suicide, Distress, Emotional
Interventions: Treatment as usual, Barrier Reduction Intervention; Behavioral
Lead sponsor: Harvard University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Otitis Media
Interventions: Cranial osteopathic manipulative treatment., Echinacea purpurea, Sham osteopathic manipulative treatment, "Echinacea purpurea" placebo; Procedure · Dietary Supplement
Lead sponsor: University of Arizona; Other
Eligibility: 12 Months to 60 Months
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2002
U.S. locations: 3
States / cities: Tucson, Arizona

Conditions: Otitis Media
Interventions: Hyland's earache drops; Drug
Lead sponsor: University of Washington; Other
Eligibility: 6 Months to 11 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 3
States / cities: Mercer Island, Washington • Renton, Washington • Seattle, Washington

Conditions: Intraocular Melanoma, Melanoma (Skin)
Interventions: incomplete Freund's adjuvant, multi-epitope melanoma peptide vaccine, sargramostim; Biological
Lead sponsor: University of Virginia; Other
Eligibility: 12 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Cognitive Ability, General, Dietary Modification
Interventions: SLOW Carbohydrate, MEDIUM Carbohydrate, FAST Carbohydrate; Other
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 9 Years to 10 Years
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Nutrition, Healthy Diet, Food Preferences
Interventions: UPF Warning Labels, No Labels (Control); Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 13 Years to 29 Years
Enrollment: 1,012 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma
Interventions: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group, Health Care Delivery, Health Promotion, Health Promotion and Education, Health Risk Assessment, Implementation, Informational Intervention, Internet-Based Intervention, Interview, Outreach, Patient Navigation, Survey Administration; Other · Behavioral · Procedure
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: Not listed
Enrollment: 2,067 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: CVD, Sedentary Behavior
Interventions: Hoosier Sport Re-Social; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 14 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Bloomington, Indiana • Lyons, Indiana

Conditions: Craniopharyngioma
Interventions: Radical Surgery or Limited Surgery, Proton Therapy, ^1^8F-fluorodeoxyglucose, ^1^1C-methionine; Procedure · Device · Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2031
U.S. locations: 2
States / cities: Jacksonville, Florida • Memphis, Tennessee

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Cetuximab, BIBW 2992; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 4
States / cities: Aurora, Colorado • New Haven, Connecticut • New York, New York + 1 more

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Sensory-Play Based (SenPlay) Intervention, Spontaneous, Free Play; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 36 Months to 71 Months
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Yukon, Oklahoma

Conditions: Attitude, Intention
Interventions: Control bar code label, Warning label, Informational campaign poster about added-sugar warning labels; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 99 Years
Enrollment: 2,275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Davis, California

Conditions: Waterpipe Size
Interventions: Waterpipe size; Other
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 21 Years to 39 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Kidney Failure, Acute
Interventions: Not listed
Lead sponsor: Abbott RDx Cardiometabolic; Other
Eligibility: 18 Years and older
Enrollment: 355 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 10
States / cities: Denver, Colorado • Washington D.C., District of Columbia • Portland, Maine + 6 more

Conditions: Body Image Disturbance, Eating Disorder Symptom, Eating Behavior, Dysmorphic Features, Dysmorphic Disorder, Body, Dysmorphia, Eating Disorders, Exercise, Compulsive
Interventions: Media Advocacy (MA), More than Muscles (MTM); Behavioral
Lead sponsor: Auburn University; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 241 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Food Selection
Interventions: Control (QR) Labels, Low Environmental Harm Labels, High Environmental Harm Labels, Environmental Harm Traffic Light Labels, Environmental Grade Labels; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 7,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Infertility, Female, Reproductive Techniques, Assisted, Fertilization in Vitro
Interventions: Intracytoplasmic Sperm Injection (ICSI), Conventional Insemination (IVF); Procedure
Lead sponsor: Shady Grove Fertility Reproductive Science Center; Other
Eligibility: Female only
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Health Status Unknown
Interventions: Lifestyle and Values Intervention, Lifestyle Intervention, Survey Administration; Other
Lead sponsor: Jerod L Stapleton, PhD; Other
Eligibility: 18 Years to 25 Years · Female only
Enrollment: 407 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases, Respiratory Tract Infections
Interventions: Low dose of quadrivalent VLP vaccine, Medium dose of quadrivalent VLP vaccine, High dose of quadrivalent VLP vaccine, Placebo; Biological
Lead sponsor: Medicago; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Hollywood, Florida • Miami, Florida

Conditions: Substance-Related Disorders
Interventions: Brief computer-delivered intervention; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Food Selection
Interventions: Control (QR) Labels, Warning High Climate Impact Labels, Traffic Light Labels, Climate Grade Labels, Numeric Carbon Footprint Labels; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 6,622 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Home Parenteral Nutrition, Short Bowel Syndrome
Interventions: SMOFLipid, Standard therapy; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Facet Joints; Degeneration, Back Pain, Facet Joint Pain
Interventions: Alocyte low dose, Alocyte medium dose, Alocyte high dose; Drug
Lead sponsor: Alimorad Farshchian; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: North Miami, Florida

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: BI 1744 CL plus tiotropium bromide, Respimat® Inhaler; Drug · Device
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 5
States / cities: Clearwater, Florida • Tampa, Florida • Philadelphia, Pennsylvania + 2 more

Search by objective public record fields.

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)

Echinacea Purpurea and Osteopathy in Children With Recurrent Otitis Media

Homeopathic Ear Drops for Otitis Media Study

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition

Effects of UPF Warning Labels on Social Media Among Teens and Young Adults

The Ohio State University (OSU) SCREEN Community Program

Hoosier Sport Re-Social: A Biobehavioral Intervention in Rural Indiana

A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer

Sensory-Play Based (SenPlay) Intervention for Young Children With or At Risk for ADHD

Evaluation of a Beverage Media Campaign and Added-sugar Warning Labels

Effect of Waterpipe Size on Smoking Behavior and Exposures

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury

Evaluating Body Acceptance Programs for Young Men

Testing Non-Nutrition Menu Labels on Food Selections

SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques

Social-Media Intervention in Reducing Tanning in High-Risk Tanners

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

Interactive Motivational Media for Perinatal Drug Abuse - 3

Climate Impact Label Design and Fast-Food Meal Selection

SMOFLipid in Patients Who Are Intralipid Intolerant

Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)